1: Szychowski J, Papp R, Dietrich E, Liu B, Vallée F, Leclaire ME, Fourtounis J,
Martino G, Perryman AL, Pau V, Yin SY, Mader P, Roulston A, Truchon JF, Marshall
CG, Diallo M, Duffy NM, Stocco R, Godbout C, Bonneau-Fortin A, Kryczka R,
Bhaskaran V, Mao D, Orlicky S, Beaulieu P, Turcotte P, Kurinov I, Sicheri F,
Mamane Y, Gallant M, Black WC. Discovery of an Orally Bioavailable and Selective
PKMYT1 Inhibitor, RP-6306. J Med Chem. 2022 Aug 11;65(15):10251-10284. doi:
10.1021/acs.jmedchem.2c00552. Epub 2022 Jul 26. PMID: 35880755; PMCID:
PMC9837800.
2: Gallo D, Young JTF, Fourtounis J, Martino G, Álvarez-Quilón A, Bernier C,
Duffy NM, Papp R, Roulston A, Stocco R, Szychowski J, Veloso A, Alam H, Baruah
PS, Fortin AB, Bowlan J, Chaudhary N, Desjardins J, Dietrich E, Fournier S,
Fugère-Desjardins C, Goullet de Rugy T, Leclaire ME, Liu B, Bhaskaran V, Mamane
Y, Melo H, Nicolas O, Singhania A, Szilard RK, Tkáč J, Yin SY, Morris SJ, Zinda
M, Marshall CG, Durocher D. CCNE1 amplification is synthetic lethal with PKMYT1
kinase inhibition. Nature. 2022 Apr;604(7907):749-756. doi:
10.1038/s41586-022-04638-9. Epub 2022 Apr 20. PMID: 35444283; PMCID: PMC9046089.
3: Qi X, Li G, Liu J, Mou L, Zhang Y, Guo S, Chen X, Li W. Structural and
energetic insights into the selective inhibition of PKMYT1 against WEE1. J
Biomol Struct Dyn. 2023 Jun 22:1-9. doi: 10.1080/07391102.2023.2225106. Epub
ahead of print. PMID: 37345529.
